Abstract
We are—it seems—finally at that long anticipated threshold of a scientific understanding of human behavior. Although this vast area of unexplored territory in human physiology remains essentially still inviolate, we are beginning our early exploratory thrusts.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes and References
Willard Gaylin, “The Frankenstein Factor,” New England Journal of Medicine, September 22, 1977, pp. 665–666.
Gerald L. Klerman, “Psychotropic Hedonism vs. Pharmacological Calvinism,” Hastings Center Report, 2: 4, September 1972, pp. 1–3.
Gerald L. Klerman“Human Beta-Endorphin: the Real Opium of the People,” British Medical Journal, July 15, 1978.
This means that (1) they produce the same pharmacological effects as the opioid agonists (e.g., morphine), and that (2) they are antagonized by naloxone.
Karl Vereby et al., “Endorphins in Psychiatry: an Overview and a Hypothesis,” Archives of General Psychiatry, 35: 7, July 1978.
Karl Vereby, op. cit, p. 880
Vincent P. Dole and Marie Nyswander, “A Medical Treatment for Diacetylmorphine (heroin) Addiction,” Journal of the American Medical Association 193, August 23, 1965, pp. 646–650.
Edward Jay Epstein, “Methadone: the Forlon Hope” The Public Interest, Summer 1974, pp. 3–23
Dorothy Nelkin, Methadone Maintenance: A Technological Fix, New York: George Braziller, 1973
Ronald Bayer, “Methadone Under Attack” Contemporary Drug Problems, Fall 1978, pp. 367–400.
Vincent P. Dole and Marie Nyswander, “Heroine Addiction—a Metabolic Disorder,” Archives of Internal Medicine, 120, July 1962.
Haldi and W. Wynn, “Action of Drugs on Efficiency of Swimmers,” Research Quarterly 17, pp. 96–101
G. M. Smith and H. K. Beecher, “Amphetamine Sulphate and Athletic Performance: I. Objective Effects,” Journal of the American Medical Association 170, 1959, pp. 542–557.
Melvin Williams, “Blood Doping: Does it Really Help Athletes?” Physician and Sports Medicine, January 1975, pp. 52–55.
Robert Neville: What moral difference does it make if there is a biological impairment? What happens if you have a kid who behaves in a way that lots of people don’t like? And you find that there’s a drug that would cure him, and he and everybody else wants to take the drug that would cure him, even though there is no biological impairment? Hein: Not cure him. Control his behavior.” In: MBD, Drug Research and the Schools, special supplement Hastings Center Report 6, June 1976.
The New York Times, April 19, 1973, pp. 1–25.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 The Humana Press Inc.
About this chapter
Cite this chapter
Gaylin, W. (1984). Feeling Good and Doing Better. In: Murray, T.H., Gaylin, W., Macklin, R. (eds) Feeling Good and Doing Better. Contemporary Issues in Biomedicine, Ethics, and Society. Humana Press. https://doi.org/10.1007/978-1-4612-5168-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5168-2_1
Publisher Name: Humana Press
Print ISBN: 978-1-4612-9594-5
Online ISBN: 978-1-4612-5168-2
eBook Packages: Springer Book Archive